Literature DB >> 3983887

Surgical treatment of primary lung cancer and solitary brain metastasis.

A Mussi, A Janni, M Pistolesi, V Ravelli, R Buonaguidi, C A Angeletti.   

Abstract

Twenty patients with carcinoma of the lung and a brain metastasis have undergone combined lung and brain surgery, which was synchronous in five. There were no operative deaths. Survival from the first surgical intervention was less than one year (3-10 months) in four patients (20%), one to two years in four (20%) and more than two years (26-66 months) in five patients (25%). Seven patients (35%) are alive and well after an average period of three years and three months (15-66 months). Actuarial survival at five years is 33.6%. All patients had severe neurological symptoms and 18 (90%) had a complete remission. Our experience and data reported in the literature point to the effectiveness of combined lung and brain surgery in prolonging symptom free survival in patients with lung cancer and solitary brain metastasis.

Entities:  

Mesh:

Year:  1985        PMID: 3983887      PMCID: PMC460026          DOI: 10.1136/thx.40.3.191

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  14 in total

1.  Intracranial metastases.

Authors:  P RICHARDS; W McKISSOCK
Journal:  Br Med J       Date:  1963-01-05

2.  Metastatic tumors of the brain: a follow-up study of 195 patients with neurosurgical considerations.

Authors:  M D SIMIONESCU
Journal:  J Neurosurg       Date:  1960-05       Impact factor: 5.115

3.  Results of surgical treatment of intracranial metastasis from pulmonary cancer; report of a case with five-year survival.

Authors:  L BAKAY
Journal:  J Neurosurg       Date:  1958-05       Impact factor: 5.115

4.  Metastatic tumors of the brain and their relation to primary and secondary pulmonary cancer.

Authors:  E M KNIGHTS
Journal:  Cancer       Date:  1954-03       Impact factor: 6.860

5.  METASTATIC TUMOURS OF BRAIN.

Authors:  M I Tom
Journal:  Can Med Assoc J       Date:  1946-03       Impact factor: 8.262

6.  Twelve-year "cure" of lung cancer with metastasis to the brain.

Authors:  W H Mosberg
Journal:  JAMA       Date:  1976-06-21       Impact factor: 56.272

7.  Bronchogenic carcinoma with a brain metastasis: a continuing challenge.

Authors:  T A Salerno; J R Little; D D Munro
Journal:  Ann Thorac Surg       Date:  1979-03       Impact factor: 4.330

8.  Proceedings: Frequency, diagnosis, and treatment of brain metastases in 247 consecutive patients with bronchogenic carcinoma.

Authors:  S J Newman; H H Hansen
Journal:  Cancer       Date:  1974-02       Impact factor: 6.860

9.  Intracranial metastases and their neurosurgical treatment.

Authors:  R G Vieth; G L Odom
Journal:  J Neurosurg       Date:  1965-10       Impact factor: 5.115

10.  Pulmonary neoplasm with solitary cerebral metastasis. Results of combined excision.

Authors:  D J Magilligan; J S Rogers; R S Knighton; J C Davila
Journal:  J Thorac Cardiovasc Surg       Date:  1976-11       Impact factor: 5.209

View more
  4 in total

1.  The prognostic factors of lung cancer patients with brain metastases treated with radiotherapy.

Authors:  C Y Hsiung; S W Leung; C J Wang; S K Lo; H C Chen; L M Sun; F M Fang
Journal:  J Neurooncol       Date:  1998-01       Impact factor: 4.130

2.  Surgery in bronchial carcinoma with metastasis.

Authors:  J Hasse
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 3.  Surgical treatment of brain metastases of lung cancer: retrospective analysis of 89 cases.

Authors:  H Nakagawa; Y Miyawaki; T Fujita; S Kubo; K Tokiyoshi; K Tsuruzono; K Kodama; M Higashiyama; O Doi; T Hayakawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

4.  Results of surgical resection in lung cancer with synchronous brain metastasis.

Authors:  Volkan Baysungur; Çagatay Tezel; Hakan Kıral; Bora Gürer; Serda Metin Kanbur; Levent Alpay; Talha Doğruyol; Deniz Gürer; Hakan Yılmaz
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2019-04-24       Impact factor: 0.332

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.